Profil
Greg Parekh, PhD
Founder & Managing Partner
Greg Parekh is the founder and a Managing Partner of New Rhein.
Before launching New Rhein, Greg led the integration planning for Alcon on behalf of Novartis AG, where he previously ran the Mergers & Acquisitions group from 2004 to 2009.
During his time at Novartis, Greg helped execute over 20 transactions with a total deal value of more than $70 billion.
Prior to joining Novartis, Greg headed Deutsche Bank’s European Healthcare Group from 1998 to 2004.
Greg joined Deutsche Bank from Bear Stearns in New York, where he started his career in 1995 as an associate in the Life Sciences group.
Greg has served as a director of the companies in which New Rhein made it initial deal-by-deal investments, Novagali Pharma, SA (a Paris, France based ophthalmology company), Chase Pharmaceuticals, a U.S.
Alzheimer’s drug company, and Biocartis NV, a Belgian oncology diagnostics company, for which Greg also served as Chief Executive Officer from 2011 to 2013.
Greg presently serves on the boards of Fund 18 portfolio companies, Softhale NV and Neuraptive Therapeutics, Inc., Butterfly Medical Ltd. and is a director of Cancerlinq, a big-data digital healthcare platform and wholly owned subsidiary of the American Society of Clinical Oncology (ASCO).
Greg holds a Ph.D.
in Economics from Northwestern University, an executive leadership program certificate from Harvard Business School and a dual-major B.A. from University of Rochester (magna cum laude).
Greg's hobbies include gourmet cooking, downhill skiing and music.
Postes actifs de Greg Parekh
| Sociétés | Poste | Début |
|---|---|---|
Everlam SA | Président | - |
Softhale NV
Softhale NV Miscellaneous Commercial ServicesCommercial Services Engages in research and development activities of natural science and engineering | Directeur/Membre du Conseil | - |
Neuraptive Therapeutics, Inc.
Neuraptive Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops and manufactures novel therapies for peripheral nerve injuries | Directeur/Membre du Conseil | 01/01/1990 |
New Rhein Healthcare Investors
New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors invests in companies located in the United States. The firm targets operating in the fields of of pharma and medical devices. It provides financing for seed, early and late-stage transactions. | Fondateur | 01/09/2010 |
CancerLinQ LLC
CancerLinQ LLC Data Processing ServicesTechnology Services Collects and analyzes real-world cancer care data from multiple healthcare IT systems | Directeur/Membre du Conseil | - |
Butterfly Medical Ltd. /Isreal/
Butterfly Medical Ltd. /Isreal/ Medical SpecialtiesHealth Technology Develops implantable device for the treatment of benign prostatic hyperplasia | Directeur/Membre du Conseil | 01/07/2020 |
American Injectables, Inc.
American Injectables, Inc. Pharmaceuticals: MajorHealth Technology Manufactures parenteral drugs | Directeur/Membre du Conseil | 01/08/2020 |
Anciens postes connus de Greg Parekh
| Sociétés | Poste | Fin |
|---|---|---|
| BIOCARTIS GROUP NV | Directeur Général | 01/04/2013 |
Chase Pharmaceuticals Corp.
Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops novel medications for the treatment of Alzheimer’s disease | Directeur/Membre du Conseil | - |
| ░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░ ░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░ ░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░░ | - |
Formation de Greg Parekh
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Rochester Christian University
Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Deutsche Bank AG
Deutsche Bank AG Investment Banks/BrokersFinance Provides investment and corporate banking & asset management services | Finance |
Chase Pharmaceuticals Corp.
Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops novel medications for the treatment of Alzheimer’s disease | Health Technology |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New Rhein Healthcare LLC
New Rhein Healthcare LLC Investment ManagersFinance Operates private equity investment company | Finance |
New Rhein Healthcare Investors
New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors invests in companies located in the United States. The firm targets operating in the fields of of pharma and medical devices. It provides financing for seed, early and late-stage transactions. | Finance |
Biocartis Group NV
Biocartis Group NV Medical SpecialtiesHealth Technology Develops molecular diagnostic instruments for immunodiagnostics | Health Technology |
Everlam SA | |
CancerLinQ LLC
CancerLinQ LLC Data Processing ServicesTechnology Services Collects and analyzes real-world cancer care data from multiple healthcare IT systems | Technology Services |
Softhale NV
Softhale NV Miscellaneous Commercial ServicesCommercial Services Engages in research and development activities of natural science and engineering | Commercial Services |
Neuraptive Therapeutics, Inc.
Neuraptive Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops and manufactures novel therapies for peripheral nerve injuries | Commercial Services |
Butterfly Medical Ltd. /Isreal/
Butterfly Medical Ltd. /Isreal/ Medical SpecialtiesHealth Technology Develops implantable device for the treatment of benign prostatic hyperplasia | Health Technology |
American Injectables, Inc.
American Injectables, Inc. Pharmaceuticals: MajorHealth Technology Manufactures parenteral drugs | Health Technology |
















